Table 1.

Transfusion use in the Stanford Translational Research Integrated Database Environment (STRIDE) compared with the literature

ReferenceReceived transfusions (%)Median follow-up length
This study 19 (65) 4.9 y (range, 0.1-15.1 y) 
11 44 (51) 5.0 y (range, 0.0-21.0 y) 
26 4 (100) Not specified 
27 23 (48) 5.0 y (0.6-25.0 y) 
28 12 (80) 4.2 y (0.3-15.7 y)* 
20 11 (55) Transfusions received in the 3 mo before the clinical trial 
16 36 (40) Patients identified and followed up between January 1, 1970 and May 25, 2012 
ReferenceReceived transfusions (%)Median follow-up length
This study 19 (65) 4.9 y (range, 0.1-15.1 y) 
11 44 (51) 5.0 y (range, 0.0-21.0 y) 
26 4 (100) Not specified 
27 23 (48) 5.0 y (0.6-25.0 y) 
28 12 (80) 4.2 y (0.3-15.7 y)* 
20 11 (55) Transfusions received in the 3 mo before the clinical trial 
16 36 (40) Patients identified and followed up between January 1, 1970 and May 25, 2012 
*

Both warm AIHA and CAD patients.

or Create an Account

Close Modal
Close Modal